Fonto IAP

Fonto Integrated Authoring Platform - which launched at DIA Europe in March - dramatically reduces the complexities involved in regulatory submissions for pharmaceutical companies by simplifying the content creation, review, publishing process. Developed in partnership with leading pharmaceutical companies, Fonto transforms the time-consuming task of drafting, editing and reviewing critical business documents - including regulatory submissions and drug applications - into a straightforward, efficient process. Its user-friendly interface, similar to Microsoft Word, allows experts to collaborate centrally, enhancing the speed and quality of document production. Fonto IAP seamlessly integrates with external data sources, automating the creation of working documents. It also ensures consistency of content through templates and standardization, ensuring all documents are compliant with regulatory requirements. Customer testimonials ""We're delighted to announce the availability of Fonto IAP,"" explains Jan Benedictus, Managing Director, Fonto. ""The technology is born out of a close collaboration between our pharma clients and the Fonto and Tridion teams, resulting in a breakthrough for regulated companies with heavy demands on content creation."" ""We release five new products to the market per year and that number is growing. Per new drug application, our scientists spend 800 days on automatable work, i.e. collecting, retyping, changing, inserting and formatting content and data. We needed to speed up these processes and reduce the amount of costly manual work. That's why we've introduced Fonto IAP,"" according to a Digital Transformation Program Lead at a large pharmaceutical company."\